<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7904301</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4537</journal-id>
<journal-id journal-id-type="nlm-ta">J Autism Dev Disord</journal-id>
<journal-id journal-id-type="iso-abbrev">J Autism Dev Disord</journal-id>
<journal-title-group>
<journal-title>Journal of autism and developmental disorders</journal-title>
</journal-title-group>
<issn pub-type="ppub">0162-3257</issn>
<issn pub-type="epub">1573-3432</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30430320</article-id>
<article-id pub-id-type="pmc">6596989</article-id>
<article-id pub-id-type="doi">10.1007/s10803-018-3804-6</article-id>
<article-id pub-id-type="manuscript">NIHMS1032458</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Prevalence and Predictors of Anxiety Disorders in Adolescent and Adult Males with Autism Spectrum Disorder and Fragile X Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ezell</surname>
<given-names>Jordan</given-names>
</name>
<degrees>MA</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hogan</surname>
<given-names>Abigail</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fairchild</surname>
<given-names>Amanda</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hills</surname>
<given-names>Kimberly</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Klusek</surname>
<given-names>Jessica</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abbeduto</surname>
<given-names>Leonard</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roberts</surname>
<given-names>Jane</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Psychology, University of South Carolina, Columbia, SC, USA</aff>
<aff id="A2"><label>2</label>Communication Sciences and Disorders, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA</aff>
<aff id="A3"><label>3</label>MIND Institute and Department of Psychiatry and Behavioral Sciences, University of California Davis, Sacramento, CA, USA</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Author’s Note</p>
<p id="P2">Jordan Ezell, Abigail Hogan, Amanda Fairchild, Kimberly Hills, &amp; Jane Roberts, Department of Psychology, University of South Carolina, Columbia, SC, USA</p>
<p id="P3">Jessica Klusek, Communication Sciences and Disorders, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA</p>
<p id="P4">Leonard Abbeduto, MIND Institute and Department of Psychiatry and Behavioral Sciences, University of California Davis, Sacramento, CA, USA</p>
</fn>
<corresp id="CR1"><bold>Corresponding Author:</bold> Dr. Jane Roberts, Department of Psychology, University of South Carolina, 1512 Pendleton Street, Barnwell College, Suite 220, Columbia, South Carolina, 29208. Phone: (803)-777-4137, <email>jerobert@mailbox.sc.edu</email></corresp>
<corresp id="CR2">Correspondence concerning this article should be addressed to Jordan Ezell, Department of Psychology, University of South Carolina, 1512 Pendleton Street, Barnwell College, Suite 220, Columbia, South Carolina, 29208. Phone: (859)-609-2591, <email>jaezell@email.sc.edu</email></corresp>
<fn fn-type="COI-statement" id="FN5">
<p id="P41"><bold>Conflict of Interest:</bold> Jordan Ezell declares that she has no conflict of interest. Abigail Hogan declares that she has no conflict of interest. Amanda Fairchild declares that she has no conflict of interest. Kimberly Hills declares that she has no conflict of interest. Jessica Klusek declares that she has no conflict of interest. Leonard Abbeduto declares that he has no conflict of interest. Jane Roberts declares that she has no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>3</month>
<year>2020</year>
</pub-date>
<volume>49</volume>
<issue>3</issue>
<fpage>1131</fpage>
<lpage>1141</lpage>
<!--elocation-id from pubmed: 10.1007/s10803-018-3804-6-->
<abstract id="ABS1">
<p id="P5">Anxiety disorders affect ~15–20% of youths without neurodevelopmental disorders, with persons having autism spectrum disorder (ASD) and fragile X syndrome (FXS) at elevated risk for anxiety disorders. Few studies have compared rates and predictors of anxiety disorders in adolescents with FXS or ASD. This study directly compares rates, predictors, and medication of anxiety disorders between age-matched, male adolescents with FXS (<italic>n</italic> = 31) or ASD (<italic>n</italic> = 20). Results indicate that 51.6% of FXS and 50.0% of ASD adolescents met criteria for an anxiety disorder. Cognitive scores and ASD severity did not predict anxiety. Of those with anxiety, ~40% of the FXS and 20% of the ASD participants were prescribed medications for anxiety.</p>
</abstract>
<kwd-group>
<kwd>autism spectrum disorder</kwd>
<kwd>fragile x syndrome</kwd>
<kwd>anxiety</kwd>
<kwd>intellectual disability</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>